Global Longlife Hospital and Research Ltd - Stock Valuation and Financial Performance

BSE: 543520 | NSE: | Hospital & Healthcare Services | Small Cap

Global Longlife Hosp Share Price

39.05 -1.10 -2.74%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Global Longlife Hosp

M-Cap below 100cr DeciZen not available

Global Longlife Hospital and Research stock performance -

mw4me loader
P/E Ratio (SA):
22.44
Market Cap:
41 Cr.
52-wk low:
36.3
52-wk high:
61.7

Is Global Longlife Hospital and Research Ltd an attractive stock to invest in?

1. Is Global Longlife Hospital and Research Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Global Longlife Hospital and Research Ltd is a average quality company.

2. Is Global Longlife Hospital and Research Ltd undervalued or overvalued?

The key valuation ratios of Global Longlife Hospital and Research Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Global Longlife Hospital and Research Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Global Longlife Hospital and Research Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Global Longlife Hosp:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Global Longlife Hospital and Research Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 7.2%2.3%11.4%16.8%4.3%-
Value Creation
Index
-0.5-0.8-0.20.2-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 34.533.532.732.823.524
Sales YoY Gr.--2.9%-2.5%0.4%-28.4%-
Adj EPS 2-1.22.95.21.71.7
YoY Gr.--163.1%NA77.1%-66.3%-
BVPS (₹) 0014.52058.958.9
Adj Net
Profit
1.4-0.92.13.61.82
Cash Flow from Ops. 5.43.96.99.4-40.4-
Debt/CF from Ops. 562.50.9-0.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA-11.2%-28.4%
Adj EPS NANANA-66.3%
BVPSNANANA195%
Share Price - - - -16.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
11.1-7.216.323.64.53
Op. Profit
Mgn %
19.510.116.625.317.3NAN
Net Profit
Mgn %
4-2.66.3117.87.8
Debt to
Equity
2.22.11.70.60.2-
Working Cap
Days
02061651254780
Cash Conv.
Cycle
05633431030

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.15

Return on Equity has declined versus last 3 years average to 3.00%

Sales growth has been subdued in last 3 years -11.18%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Global Longlife Hospital and Research Ltd.

Standalone Consolidated
TTM EPS (₹) 1.7 -
TTM Sales (₹ Cr.) 23.5 -
BVPS (₹.) 58.9 -
Reserves (₹ Cr.) 54 -
P/BV 0.66 -
PE 22.44 -
From the Market
52 Week Low / High (₹) 36.25 / 61.70
All Time Low / High (₹) 36.25 / 141.10
Market Cap (₹ Cr.) 41
Equity (₹ Cr.) 10.5
Face Value (₹) 10
Industry PE 83.6

Management X-Ray of Global Longlife Hosp:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Global Longlife Hosp

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Sales34.5433.5432.7032.8223.50
Operating Expenses 27.7930.1627.2724.5819.43
Manufacturing Costs15.1219.5213.5214.219.71
Material Costs4.345.068.593.604.33
Employee Cost 4.284.063.423.523.03
Other Costs 4.051.511.743.252.36
Operating Profit 6.753.395.448.234.07
Operating Profit Margin (%) 19.5%10.1%16.6%25.1%17.3%
Other Income 0.190.110.060.230.24
Interest 2.092.442.431.610.43
Depreciation 2.152.131.311.141.17
Exceptional Items 00000
Profit Before Tax 2.69-1.061.765.712.71
Tax 1.32-0.20-0.292.140.88
Profit After Tax 1.36-0.862.053.571.83
PAT Margin (%) 4.0%-2.6%6.3%10.9%7.8%
Adjusted EPS (₹)2.0-1.22.95.11.7
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 12.3511.4913.6816.9664.29
Share Capital 777710.50
Reserves 5.354.496.689.9653.79
Minority Interest00000
Debt23.5522.9115.32-0.999.14
Long Term Debt17.7216.8912.512.823.64
Short Term Debt5.836.032.81-3.815.50
Trade Payables2.745.433.264.281.31
Others Liabilities 1.47-1.300.7611.15-0.95
Total Liabilities 40.1238.5333.0231.4073.79

Fixed Assets

Gross Block21.7420.2725.7426.1427.11
Accumulated Depreciation1.581.558.289.4210.59
Net Fixed Assets20.1718.7217.4616.7116.52
CWIP 00001.03
Investments 0.100.100.470.100.10
Inventories2.022.190.810.880.82
Trade Receivables8.696.277.848.919.70
Cash Equivalents 0.481.290.440.223.60
Others Assets8.669.9664.5842.03
Total Assets 40.1238.5333.0231.4073.79

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 5.403.906.889.42-40.42
PBT 2.69-1.061.765.712.71
Adjustment 4.164.474.102.892.02
Changes in Working Capital -1.440.491.020.16-43.87
Tax Paid 0000.67-1.27
Cash Flow From Investing Activity -0.33-0.040.020.01-1.90
Capex -0.40-0.11-0.04-0.46-2
Net Investments 0000.27-0.02
Others 0.070.070.060.200.12
Cash Flow From Financing Activity -4.77-3.05-7.22-9.6645.70
Net Proceeds from Shares 200045.50
Net Proceeds from Borrowing -3.44-0.83-4.94-9.690.82
Interest Paid -2.07-2.41-2.28-1.31-0.40
Dividend Paid 00000
Others -1.260.1901.34-0.22
Net Cash Flow 0.310.81-0.33-0.223.38
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)11.05-7.2318.9429.654.82
ROCE (%)12.093.6913.4929.366.69
Asset Turnover Ratio0.860.850.911.020.45
PAT to CFO Conversion(x)3.97N/A3.362.64-22.09
Working Capital Days
Receivable Days92817993144
Inventory Days212317913
Payable Days231295185382235

Global Longlife Hospital and Research Ltd Stock News

Global Longlife Hospital and Research Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Global Longlife Hosp on 28-Mar-2024 16:01 is ₹39.05.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Global Longlife Hosp stood at ₹41.00.
The latest P/E ratio of Global Longlife Hosp as of 28-Mar-2024 16:01 is 22.44.
The latest P/B ratio of Global Longlife Hosp as of 28-Mar-2024 16:01 is 0.66.
The 52-week high of Global Longlife Hosp is ₹61.70 and the 52-week low is ₹36.25.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Global Longlife Hosp is ₹23.50 ( Cr.) .

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research is known as a Multi Speciality Tertiary Care Hospital of Gujarat with many beds well equipped for Medical & Surgical Specialities. It provides platform to the doctors for treatment of their patients. The company has adopted the Standard Operating Procedures (SOPs) given by Ministry of Health & Family Welfare. Under the said SOPs every work function of its hospital is defined, every process is written down and every employee is trained in his/her duties as soon as he/she joins. Every equipment is maintained as per a predefined schedule. Every necessary license is obtained and renewed as required time to time. The company is certified by National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited) which is committed to support improvement of quality of healthcare service in its country for all strata of the population through various methodologies and tools to supplement the efforts of the providers of healthcare service and the requirements of the system at various levels. The main purpose of the company’s promoter is to serve the people, hence, the company is also following the same path for which it put its ethics above the all cost. Through the Mukhya Mantri Amrutum Yojana the company has served over 6,000 patients up till now.

The company has invested in, and have established a IT system both for clinical purposes as well as integrating systems and processes through HMS (Hospital Management System)which includes Central Registration module, Appointment, Barcode Generation, Case Paper Generation, OPD Billing, Procedure billing, IPD Registration, Advance & Refund, Due billing, TPA/Package Billing, User Management, Doctor Sharing, Software Security, Management Reports, Discharge Summary towards streamlining its clinical and administrative functions. It has adopted technology with a view to ensure quick transmission of disease data, subsequent analysis, and prompt disease management.

Business area of the company

The company provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services. Global Longlife Hospital is certified by the National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited).

Major Events, Key Awards, Accreditations or Recognition

  • 2016: The company has received Leadership award of ‘Best emerging hospital of India’ by The Associated Chambers of Commerce and Industry of India.
  • 2018: The company has received ‘Global Achievers Awards For Health Excellence’ for outstanding achievement in Health and Social Services at 12th International Achievers on 'Global Business Opportunities', Dubai, UAE.
  • 2018: Certificate of Recognition as ‘Times Health Icon’ by Times Health Icon 2018 - A Times Group Company.
  • 2021: Certificate of Recognition as ‘Most Trusted Hospital’ by Times Healthcare Leaders Ahmedabad, 2021 - A Times Group Company.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.